Sofinnova Partners, a European venture capital firm specialized in Life Sciences, has appointed Dr. Martin T. Rothman as Venture Partner.
As Venture Partner, Dr. Rothman will focus on helping the team identify and evaluate promising medical device companies and on mentoring entrepreneurs and physicians launching clinical innovations.
Dr. Rothman brings forty years of experience and an international network in the medical field to Sofinnova Partners, being the founder of LimFlow and an independent board member of HighLife, both portfolio companies of the firm,
Until recently, he was Vice President of medical affairs for coronary, structural heart and renal denervation for Medtronic, based in Santa Rosa (CA), a position he held since 2010. Dr. Rothman previously practiced during 37 years in the U.K. as an interventional cardiologist, including 27 years at the London Chest Hospital (Barts and the London NHS Trust), where he has served for more than a decade as director of cardiac research and development.
Dr. Rothman is world renowned for his contributions to clinical research, training and education, and medical technology innovation in cardiovascular medicine.
He also currently holds several positions in start-up companies in the cardiovascular field, some as a founder and based on his own inventions.